Jospar 500 Tablet contains Cefuroxime 500 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exhibiting bactericidal activity. Jospar 500 is indicated for the treatment of various infections caused by susceptible organisms, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and Lyme disease. It is also used in the management of otitis media and sinusitis. The tablet formulation allows for oral administration, providing convenient dosing and good systemic absorption. Jospar 500 should be prescribed following susceptibility testing to ensure efficacy and reduce the risk of resistance development. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, as well as hypersensitivity reactions in patients with a history of beta-lactam allergy. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Jospar 500 should be used under medical supervision, adhering strictly to the prescribed dosage and duration to achieve optimal therapeutic outcomes and minimize adverse effects.